X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1056) 1056
Publication (62) 62
Newsletter (11) 11
Book Review (9) 9
Magazine Article (6) 6
Book Chapter (3) 3
Newspaper Article (2) 2
Conference Proceeding (1) 1
Data Set (1) 1
Dissertation (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (884) 884
lisinopril (623) 623
male (597) 597
female (562) 562
middle aged (475) 475
aged (392) 392
hypertension - drug therapy (391) 391
angiotensin-converting enzyme inhibitors - adverse effects (378) 378
angiotensin-converting enzyme inhibitors - therapeutic use (342) 342
lisinopril - adverse effects (313) 313
adult (287) 287
lisinopril - therapeutic use (277) 277
hypertension (254) 254
blood pressure - drug effects (212) 212
index medicus (212) 212
double-blind method (186) 186
antihypertensive agents - therapeutic use (184) 184
pharmacology & pharmacy (181) 181
antihypertensive agents - adverse effects (167) 167
enalapril (156) 156
enalapril - adverse effects (142) 142
treatment outcome (142) 142
ace inhibitors (138) 138
lisinopril - administration & dosage (133) 133
captopril (126) 126
angiotensin-converting enzyme inhibitors - administration & dosage (125) 125
enalapril - therapeutic use (123) 123
drug therapy, combination (117) 117
enalapril - analogs & derivatives (117) 117
peripheral vascular disease (117) 117
hypertension - physiopathology (116) 116
medicine, general & internal (116) 116
cardiac & cardiovascular systems (110) 110
blood-pressure (101) 101
drug therapy (101) 101
heart failure - drug therapy (98) 98
aged, 80 and over (93) 93
risk factors (91) 91
angioedema - chemically induced (89) 89
blood pressure (89) 89
time factors (88) 88
animals (81) 81
antihypertensive agents - administration & dosage (81) 81
angiotensin-converting enzyme inhibitors (78) 78
mortality (77) 77
lisinopril - pharmacology (74) 74
therapy (74) 74
angiotensin-converting enzyme inhibitors - pharmacology (73) 73
angiotensin (69) 69
prospective studies (69) 69
dose-response relationship, drug (66) 66
hypertension - complications (64) 64
adolescent (63) 63
dosage and administration (62) 62
urology & nephrology (60) 60
research (59) 59
heart failure (56) 56
follow-up studies (54) 54
health aspects (54) 54
care and treatment (53) 53
rats (53) 53
medicine & public health (52) 52
double-blind (51) 51
enzymes (51) 51
clinical trials as topic (50) 50
captopril - adverse effects (49) 49
enalapril - administration & dosage (49) 49
efficacy (48) 48
heart failure - physiopathology (48) 48
hydrochlorothiazide (48) 48
valsartan (48) 48
cough - chemically induced (47) 47
diuretics (47) 47
calcium channel blockers - therapeutic use (46) 46
drug interactions (46) 46
angiotensin-converting enzyme (45) 45
heart rate - drug effects (45) 45
renin-angiotensin system (45) 45
internal medicine (44) 44
tetrazoles - therapeutic use (44) 44
drugs (43) 43
losartan (43) 43
renin-angiotensin system - drug effects (43) 43
captopril - therapeutic use (40) 40
ace-inhibitors (39) 39
clinical trials (39) 39
converting enzyme-inhibitors (39) 39
dipeptides - adverse effects (39) 39
hemodynamics - drug effects (39) 39
retrospective studies (39) 39
trial (39) 39
angiotensin ii type 1 receptor blockers - therapeutic use (38) 38
antihypertensive drugs (38) 38
complications and side effects (38) 38
cross-over studies (38) 38
hydrochlorothiazide - adverse effects (38) 38
prevention (38) 38
antihypertensive agents - pharmacology (37) 37
diabetes (37) 37
management (37) 37
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1005) 1005
German (17) 17
Italian (9) 9
Russian (9) 9
French (8) 8
Spanish (7) 7
Danish (4) 4
Norwegian (4) 4
Dutch (2) 2
Hungarian (2) 2
Portuguese (2) 2
Swedish (2) 2
Chinese (1) 1
Croatian (1) 1
Hebrew (1) 1
Japanese (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 11/2013, Volume 369, Issue 20, pp. 1892 - 1903
Journal Article
Journal of the American Society of Nephrology, ISSN 1046-6673, 12/2009, Volume 20, Issue 12, pp. 2641 - 2650
Aldosterone promotes glomerular and tubular sclerosis independent of angiotensin II in animal models of diabetic nephropathy. Most human studies testing the... 
PRONE HYPERTENSIVE-RATS | VASCULAR INJURY | CONTROLLED-TRIAL | CARDIOVASCULAR OUTCOMES | ALDOSTERONE ANTAGONISM | HEART-FAILURE | RENAL OUTCOMES | UROLOGY & NEPHROLOGY | BLOOD-PRESSURE CONTROL | CHRONIC KIDNEY-DISEASE | ANTIHYPERTENSIVE TREATMENT | Angiotensin II Type 1 Receptor Blockers - adverse effects | Spironolactone - administration & dosage | Glycated Hemoglobin A - metabolism | Humans | Middle Aged | Diabetic Nephropathies - drug therapy | Hypertension - drug therapy | Male | Diabetic Nephropathies - physiopathology | Lisinopril - adverse effects | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Adult | Female | Bicarbonates - blood | Blood Pressure - drug effects | Albuminuria - urine | Drug Therapy, Combination | Hypertension - urine | Spironolactone - adverse effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Lisinopril - administration & dosage | Diabetic Nephropathies - urine | Mineralocorticoid Receptor Antagonists - administration & dosage | Double-Blind Method | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Creatinine - urine | Hypertension - physiopathology | Albuminuria - drug therapy | Losartan - adverse effects | Potassium - blood | Renin-Angiotensin System - drug effects | Losartan - administration & dosage | Index Medicus | Clinical Research
Journal Article
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9647, pp. 1394 - 1402
Summary Background Results of previous studies suggest that renin-angiotensin system blockers might reduce the burden of diabetic retinopathy. We therefore... 
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | RISK-FACTORS | RENIN-ANGIOTENSIN SYSTEM | CARDIOVASCULAR-DISEASE | COMPLICATIONS | LISINOPRIL | BLOOD-FLOW | HYPERTENSION | FAILURE | Hypoglycemic Agents - therapeutic use | Severity of Illness Index | Diabetic Retinopathy - drug therapy | Angiotensin II Type 1 Receptor Blockers - adverse effects | Double-Blind Method | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Humans | Middle Aged | Diabetic Retinopathy - classification | Male | Treatment Outcome | Diabetes Mellitus, Type 1 - complications | Diabetes Mellitus, Type 1 - drug therapy | Adolescent | Adult | Female | Tetrazoles - therapeutic use | Diabetic Retinopathy - etiology | Tetrazoles - adverse effects | Benzimidazoles - adverse effects | Insulin - therapeutic use | Benzimidazoles - therapeutic use | Prevention | Diabetic retinopathy | Complications and side effects | Candesartan | Type 1 diabetes | Dosage and administration | Drug therapy | Risk factors | Studies | Clinical trials | Photographs | Diabetes | Pressure measurement | Patients | Index Medicus | Abridged Index Medicus | Benzimidazoles | Tetrazoles | MEDICIN OCH HÄLSOVETENSKAP | Angiotensin II Type 1 Receptor Blockers | Hypoglycemic Agents | MEDICAL AND HEALTH SCIENCES | Type 1 | drug therapy | complications | Diabetes Mellitus | classification | Insulin | etiology | adverse effects | therapeutic use | Diabetic Retinopathy
Journal Article
Journal Article
Toxicology International, ISSN 0971-6580, 05/2013, Volume 20, Issue 2, pp. 170 - 176
Combination therapy of lisinopril and rosuvastatin may be an important concept in developing more effective strategies to treat and prevent atherosclerosis,... 
rosuvastatin | toxicity evaluation | Lisinopril | Complications and side effects | Rosuvastatin | Coronary heart disease | Atherosclerosis | Antilipemic agents | Original
Journal Article
European Journal of Preventive Cardiology, ISSN 2047-4873, 06/2017, Volume 24, Issue 9, pp. 951 - 961
Aims Cardiovascular fixed-dose combination pills, or polypills, may help address the widespread lack of access and adherence to proven medicines. Initiation of... 
cardiovascular disease | Antiplatelet | statin | polypill | blood pressure-lowering agents | prevention | Journal Article | fixed-dosed combination pill | Hydroxymethylglutaryl-CoA Reductase Inhibitors - administration & dosage | Simvastatin - adverse effects | Tablets | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Antihypertensive Agents - administration & dosage | Male | Aspirin - administration & dosage | Polypharmacy | Time Factors | Aspirin - adverse effects | Lisinopril - adverse effects | Platelet Aggregation Inhibitors - administration & dosage | Cardiovascular Diseases - blood | Cholesterol, LDL - blood | Female | Blood Pressure - drug effects | Atenolol - administration & dosage | Lisinopril - administration & dosage | Platelet Aggregation Inhibitors - adverse effects | Hydrochlorothiazide - adverse effects | Cardiovascular Diseases - etiology | Cardiovascular Diseases - physiopathology | Risk Assessment | Administration, Oral | Simvastatin - administration & dosage | Europe | Risk Factors | Treatment Outcome | Hydrochlorothiazide - administration & dosage | Biomarkers - blood | Antihypertensive Agents - adverse effects | India | Medication Adherence | Hydroxymethylglutaryl-CoA Reductase Inhibitors - adverse effects | Atenolol - adverse effects | Aged | Drug Substitution | Drug Combinations
Journal Article
Hypertension, ISSN 0194-911X, 07/2017, Volume 70, Issue 1, pp. 94 - 102
Journal Article
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 10/2018, Volume 2018, Issue 10, p. CD009068
Journal Article